Home›Companies›Biotech & Pharma›Functional Longevity Labs

Functional Longevity Labs, Inc.

Develops drugs targeting aging and Alzheimer's disease.

Updated Nov 9, 2026·Latest SEC filing Sep 21, 2026·Suggest an edit

About Functional Longevity Labs

Functional Longevity Labs is a private company based in Easton, Maryland, incorporated in 2024 in Delaware. It has reported $25,000 raised in one offering on Form D since September 2026. Its chief executive is Dr. William Smith.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 9, 2026Sep 21, 2026$25,000of $1.0M target1$25,000Simple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Functional Longevity Labs's Form D filed Sep 21, 2026.

DS
Dr. William Smith
Chair & Chief Executive Officer

Sources

  1. SECFunctional Longevity Labs, Inc. filing history